Recent research on venous thromboembolism in China: A brief report from China Venous Thromboembolism Study Group

Chinese Medical Journal

Volumn 123, Issue 4, 2010, Pages 485-490

  Zhai, Zhen Guo ^a   Zhan, Xi ^a   Yang, Yuan Hua ^a   Wang, Chen ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Deep vein thrombosis; Pulmonary thromboembolism; Venous thromboembolism

Indexed keywords

ALTEPLASE; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; STREPTOKINASE; UROKINASE;

ANIMAL MODEL; ARTICLE; CHINA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DRUG EFFICACY; DRUG SAFETY; ECHOCARDIOGRAPHY; GENETIC POLYMORPHISM; HUMAN; LUNG ANGIOGRAPHY; LUNG EMBOLISM; LUNG VENTILATION; META ANALYSIS; NONHUMAN; SYSTEMATIC REVIEW; VENOUS THROMBOEMBOLISM;

ANIMALS; CHINA; DISEASE MODELS, ANIMAL; HUMANS; POLYMORPHISM, GENETIC; VENOUS THROMBOEMBOLISM;

EID: 77149170842     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2010.04.018     Document Type: Article

References (46)

1. Tan XY, He JG, Zou ZP, Zhao YF, Chen BP, Gao Y, et al. Changes of the proportion and mortality of pulmonary thromboembolism in hospitalized patients from 1974 to 2005. Chin Med J 2006; 119: 998-1002.
2. Cai B, Xu L, Guo S. Trends of underline diseases of pulmonary embolism from Peking Union Medical College Hospital. Chin J Tuberc Respir Dis (Chin) 2001; 24: 715-717.
3. Sun KK, Wang C, Guli XT, Luo Q. Risk factors and clinical features of deep venous thrombosis: a report of 388 cases. Chin J Tuberc Respir Dis (Chin) 2004; 27: 727-730.
4. Sun KK, Wang C, Pang BS, Yang YH, He W, Chen TF, et al. Study on the risk factors of deep venous thrombosis in acute hospitalized stroke patients. Chin J Epidemiol (Chin) 2004; 25: 1019-1023.
5. Sun KK, Wang C, Pang BS, Yang YH. The prevalence of deep venous thrombosis in hospitalized patients with stroke. Natl Med J China (Chin) 2004; 84: 637-641.
6. Xu XF, Yang YH, Zhai ZG, Liu S, Zhu GF, Li CS, et al. Prevalence and incidence of deep venous thrombosis among patients in medical intensive care unit. Natl Med J China (Chin) 2008; 29: 1034-1037.
7. Li G, Lu WX, Wang C. Pulmonary embolism in cancer: clinical analysis of 60 cases. Chin J Oncol (Chin) 2009; 31: 550-553.
8. Yang YH, Guo XJ, Zhai ZG, Wang F, Wang C; National Project of the Diagnosis and Treatment Strategies for Pulmonary Thromboembolism in China. Study on the risk factors regarding deep venous thrombosis in acute pulmonary thromboembolism. Chin J Epidemiol (Chin) 2008; 29: 716-719.
9. National Project of the Diagnosis and Treatment Strategies for Pulmonary Thromboembolism (NATSPUTE). The clinical features of 516 patients with acute pulmonary thromboembolism. Natl Med J China (Chin) 2006; 86: 2161-2165.
10. Xu X, Yang Y, Wang C. The clinical features of elderly patients with pulmonary thromboembolism. Chin J Geriatr Cardiovasc Cerebrovasc Dis (Chin) 2006; 8: 665-667.
11. Chinese Thoracic Society. The guideline of diagnosis and treatment of pulmonary thromboembolism in China. Chin J Tuberc Respir Dis (Chin) 2001; 24: 259-264.
12. Zhang Z, Lu W, Wang C. Follow the guideline of pulmonary thromboembolism. Chin J Tuberc Respir Dis (Chin) 2001; 24: 705-706.
13. Dai RP, Wang C. Attach importance to standardization of medical imaging diagnosis in pulmonary thromboembolism. Chin J Tuberc Respir Dis (Chin) 2005; 28: 577-578.
14. Guo XJ, Liu M, Guo YM, Ma HX, Guo YL, Zhu L, et al. A comparison of the predictive values of three clinical scoring systems for suspected acute pulmonary embolism based on multi-detector CT angiography. Chin J Tuberc Respir Dis (Chin) 2009; 32: 119-123.
15. Zhu L, Yang Y, Wu Y, Zhai Z, Wang C. Value of right ventricular dysfunction for prognosis in pulmonary embolism. Int J Cardiol 2008; 127: 40-45.
16. Zhu L, Wang C, Yang Y, Wu Y, Zhai Z, Dai H, et al. Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism. J Thromb Thrombolysis 2008; 26: 251-256.
17. Zhu L, Yang YH, Wu YF, Zhai ZG, Wang C; National Project of the Diagnosis and Treatment Strategies for Pulmonary Thromboembolism investigators. Value of transthoracic echocardiography combined with cardiac troponin I in risk stratification in acute pulmonary thromboembolism. Chin Med J 2007; 120: 17-21.
18. Wang C, Zhai Z, Yang Y, Wu Q, Cheng Z, Liang L, et al; For China Venous Thromboembolism (VTE) Study Group. Efficacy and safety of low dose rt-PA for the treatment of acute pulmonary thromboembolism: a randomized, multi-center, controlled trial. Chest 2009; Epub ahead of print.
19. Wang C, Zhai Z, Yang Y, Yuan YD, Cheng Z, Liang L, et al. Efficacy and safety of 2-hour urokinase regime in acute pulmonary embolism: a randomized controlled trial. Respir Res 2009; 10: 128.
20. Zhai ZG, Wang C, Liu YM, Qin ZQ. Comparison of unfractionated heparin and low molecular weight heparin in pulmonary thromboembolism: meta-analysis. Acta Acad Med Sin (Chin) 2004; 26: 221-226.
21. Yang YH, Zhai ZG, Wang F, Xie WM, Wang C. Changes in deep venous thrombosis after thrombolytic anticoagulant therapies in acute pulmonary thromboembolism. Chin J Intern Med (Chin) 2009; 48: 371-374. .
22. Ren H, Su PX, Zhang CJ, Gu S, Zhang H, Wang C. Thromboendarterectomy for chronic pulmonary thromboembolism. Chin Med Sci J 2005; 20: 194-197.
23. Zhai Z, Wang C, Yang YH, Pang BS, Xiao B, Liu YM, et al. The relationship between polymorphisms of prothrombin G20210 and pulmonary thromboembolism in Chinese Han population. J Capit Med Univ (Chin) 2006; 1: 1-5.
24. Zhai ZG, Wang C, Yang YH, Pang BS, Xiao B, Liu YM, et al. Study on the relationship between polymorphisms of susceptible genes in coagulation pathway related to pulmonary thromboembolism in Chinese Han population. Chin J Epidemiol (Chin) 2006; 27: 165-169.
25. Zhai ZG, Wang C, Yang YH, Pang BS, Xiao B, Liu YM, et al. Relationship between polymorphisms of plasminogen activator inhibitor-1 promoter gene and pulmonary thromboembolism in Chinese Han population. Natl Med J China (Chin) 2006; 86: 1313-1317.
26. Zhai Z, Yin Y, Yang Y, Wang J, Wang C, Xie W. The association between thrombomodulin gene variations and thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2009; 179: A3339.
27. Zhu J, Zhang W, Li Y, Zhang W, Wang H, Zheng W, et al. ARMS test for diagnosis of CYP2C9 and VKORC1 mutation in patients with pulmonary embolism in Han Chinese. Pharmacogenomics 2010; 11: 113-119.
28. Pang BS, Wang C, Zhai ZG, Yang YH, Mao YL, Huang XX, et al. Changes of blood coagulative and fibrinolytic systems and functions of pulmonary vascular endothelium in patients with pulmonary thromboembolism. Chin J Tuberc Res Dis (Chin) 2005; 28: 714-716.
29. Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, et al. Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism. Natl Med J China (Chin) 2007; 87: 3074-3078.
30. Yin YD, Wang C, Zhai ZG, Pang BS, Yang YH, Huang XX. Decreased plasma soluble thrombomodulin levels as a risk factor for pulmonary thromboembolism. J Thromb Thrombolysis 2009; 27: 274-279.
31. Peng K, Wang C, Pang BS, Yang YH. Effects of thrombolysis and anticoagulation on the functions of vascular endothelial cells and coagulation and fibrinolysis in patients with pulmonary thromboembolism. Chin J Tuberc Res Dis (Chin) 2005; 28: 596-599.
32. Zhang Y, Yang YH, Pang BS, Wang C. The changes of serum enzymes and cardiac troponin I in patients with acute pulmonary thromboembolism. Chin J Tuberc Res Dis (Chin) 2007; 30: 667-672.
33. Wang F, Wang C, Wang T, Pang BS, Wu YB, Yang YH, et al. A canine model of acute pulmonary thromboembolism induced by autologous radioactive blood clots. Chin J Tuberc Res Dis (Chin) 2003; 26: 470-473.
34. Wang F, Wang C, Wang T, Pang BS, Wu YB, Yang YH, et al. Experimental study of the thrombolytic effects in a canine model of pulmonary thromboembolism induced by autologous radioactive blood clots. Chin J Tuberc Res Dis (Chin) 2004; 27: 93-96.
35. Wang Y, Wang C, Yang Y, Pang B. Effect of recombinant single-chain urokinase-type plasminogen activator on experimental pulmonary embolism. Clin Appl Thromb Hemost 2009; Epub ahead of print.
36. Wu Y, Wang C, Pang B, Niu S, Wang H, Zhang H, et al. The pathology of and the cardio-pulmonary functional changes in acute multiple pulmonary microthromboembolism in a canine model. Chin J Tuberc Respir Dis (Chin) 2002; 25: 217-220.
37. Liu CP, Zhang YJ, Lu WX, Ji YQ, Zhang WH, Wang C. The change of pulmonary surfactant associated protein A in acute pulmonary embolism. Chin J Tuberc Respir Dis (Chin) 2005; 28: 600-603.
38. Liu CP, Lu WX, Liu WG, Chen HW, Wang C. The low molecular weight heparin on rat pulmonary surfactant associated protein A of acute pulmonary embolism. Natl Med J China (Chin) 2007; 87: 634-636.
39. Ji YQ, Lu WX, Zhang ZH, Feng M, Wang C. Study on changes of thrombi and vessel intima in a rat venous thromboembolism model. Chin J Tuberc Respir Dis (Chin) 2009; 32: 198-202.
40. Ji YQ, Zhang ZH, Lu WX, Feng M, Wang C. Establishment of rat model of venous thromboembolism. Natl Med J China (Chin) 2009; 89: 271-275.
41. Deng CS, Wang C, Pang BS, Yang YH, Du MJ, Qi M, et al. The role of polymorphonuclear cells in lung ischemiareperfusion injury in a canine model of pulmonary thromboembolism. Chin J Tuberc Respir Dis (Chin) 2006; 29: 603-606.
42. Deng CS, Wang C, Yang YH, Pang BS, Du MJ, Zhai RY, et al. Effects of different durations of thromboembolism on blood gases, hemodynamics, pulmonary arteriography and thrombo-pathology in a canine model with selective embolization of pulmonary lobar arteries. Chin J Tuberc Respir Dis (Chin) 2006; 29: 257-260.
43. Wang C, Wang J, Zhao L, Wang Y, Liu J, Shi L, et al. Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca2+ entry. J Pharmacol Sci 2008; 108: 71-78.
44. Zhang YJ, Lu W, Xia G, Liu C, Ji Y, Zhang W, et al. Changes of monocyte chemoattractant protein-1 and platelet derived growth factor-B and pulmonary arterial remodeling associated with experimental pulmonary thromboembolism in rats. Chin J Tuberc Respir Dis (Chin) 2005; 4: 365-368.
45. Liu Y, Wang C, Yang Y, Hou X, Wang J. Pro-urokinase up-regulates the expression of urokinase-type plasminogen activator (u-PA) in human pulmonary arterial endothelial cells. Thromb Res 2008; 121: 485-491.
46. Wang C, Cheng XS, Zhong NS. Promoting the clinical and research work on pulmonary thromboembolism in China. Chin J Tuberc Respir Dis (Chin) 2004; 27: 721-722.